Achievements of Community-directed treatment with ivermectin (CDTI)
APOC’s strategy of community-directed treatment with ivermectin has brought substantial achievements for onchocerciasis control in Africa. Using this approach:
- In APOC countries, over 100.8 million people were receiving regular treatment for onchocerciasis by the end of 2012. 184 560 communities distributed ivermectin representing an overall geographic coverage of 95.4%.
- close to one million disability-adjusted life years (DALYs) have been averted
- the prevalence of infection has reduced by about 73% compared with pre-APOC levels.
An additional achievement of this strategy has been to build up a network of trained community volunteers who are helping to supplement and reinforce the traditional health care system in remote, rural areas of countries where APOC is working.
The map shows the countries where treatment is being provided to more than 65% of the total population living in onchocerciasis-endemic areas. A therapeutic coverage of 65% is APOC’s target level of coverage to achieve elimination of the disease.